Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Aug 20;31(37):3811-7.
doi: 10.1016/j.vaccine.2013.06.016. Epub 2013 Jun 15.

Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects

Jannah Wigle  1 , Ernestina Coast, Deborah Watson-Jones
Affiliations
Review

Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects

Jannah Wigle et al. Vaccine. .

Abstract

Prophylactic vaccines for human papillomavirus (HPV) are being introduced in many countries for the prevention of cervical cancer, the second most important cause of cancer-related death in women globally. This is likely to have a significant impact on the future burden of cervical cancer, particularly where screening is non-existent or limited in scale. Previous research on the challenges of vaccinating girls with the HPV vaccine has focused on evidence from developed countries. We conducted a systematic search of the literature in order to describe the barriers and challenges to implementation of HPV vaccine in low- and middle-income countries. We identified literature published post-2006 to September 2012 from five major databases. We validated the findings of the literature review with evidence from qualitative key informant interviews. Three key barriers to HPV vaccine implementation were identified: sociocultural, health systems and political. A linked theme, the sustainability of HPV vaccines programmes in low- and middle-income countries, cuts across these three barriers. Delivering HPV vaccine successfully will require multiple barriers to be addressed. Earlier research in developed countries emphasised sociocultural issues as the most significant barriers for vaccine roll-out. Our evidence suggests that the range of challenges for poorer countries is significantly greater, not least the challenge of reaching girls for three doses in settings where school attendance is low and/or irregular. Financial and political barriers to HPV vaccine roll-out continue to be significant for many poorer countries. Several demonstration and pilot projects have achieved high rates of acceptability and coverage and lessons learned should be documented and shared.

Keywords: Cervical cancer; HPV; Human papillomavirus; Low- and middle-income countries (LMICs); Sexually transmitted infection; Vaccine.

PubMed Disclaimer

References

    1. WHO/ICO . WHO; 2010. Human papillomavirus and related cancers in world. Summary report 2010.
    1. Kane M., Serrano B., de Sanjose S., Wittet S. Implementation of human papillomavirus immunization in the developing world. Vaccine. 2012;30S:F192–F200. - PubMed
    1. Forman D., de Martel C., Lacey C.J., Soerjomataram I., Lortet-Tieulent J., Bruni L. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30S:F12–F23. - PubMed
    1. Adams M., Jasani B., Fiander A. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening. Vaccine. 2007;25(16):3007–3013. - PubMed
    1. Franco E.L., Mahmud S.M., Tota J., Ferenczy A., Coutlée F. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change. Arch Med Res. 2009;40(6):478–485. - PubMed

Publication types

Substances

LinkOut - more resources